D
Develo
Revolutionary pediatric software enhancing practice efficiency and family engagement for independent pediatricians
About Develo
Develo is a pioneering company in the healthcare technology sector, specifically focusing on pediatric software solutions. The company operates in the United States, targeting independent pediatric practices. Develo's mission is to revolutionize pediatric care by providing a comprehensive software suite that addresses the unique needs of pediatricians and their young patients.
Read full description
The core offering of Develo is its integrated software platform designed to streamline various administrative and clinical tasks within pediatric practices. This includes features such as digital intake forms, e-fax integration, automated document tagging, and electronic medical records (EMR) tailored for pediatrics. By leveraging these tools, practices can enhance their operational efficiency, improve team productivity, and foster greater loyalty and satisfaction among families.
Develo's business model is subscription-based, where pediatric practices pay a recurring fee to access the software. This model ensures a steady revenue stream for the company while providing continuous support and updates to its clients. The software is designed by pediatricians, ensuring that it meets the specific needs of the field, which sets it apart from more generic EMR systems.
The market for Develo is substantial, given that children make up a third of the U.S. population. By focusing exclusively on pediatric practices, Develo addresses a significant gap in the healthcare software market. The company's approach is to move away from traditional, often cumbersome EMR workflows and towards more intuitive, seamlessly connected experiences that empower both healthcare providers and families.
In summary, Develo is setting a new standard in pediatric software by offering a tailored, comprehensive solution that enhances the efficiency and effectiveness of independent pediatric practices. The company's focus on innovation and user-centric design positions it well in a growing market.
Latest news
Press, funding announcements and product moves mentioning Develo.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2026 | $14M | $56M | Paul Black · Bienville Capital · Z21 Ventures · Blueprint Equity | ↗ |
| SEED✓Equity / VC | Oct 2023 | $2.5M | $10M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Develo is 14K monthly website visits, up 460% over the last three months. Develo's team grew 86.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Blueprint Equity
Paul Black
Bienville Capital
Z21 Ventures- CSChris Sullens
- VCVillain Capital
Chris Barton
Other known investors1 additional known investor
StartX
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Develo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Develo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







